Auerbach Mark
SEC-identified person · CIK 1018007 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Pardes Biosciences, INC. PRDS | Director | filed 2021 - 2023 |
| Ventrus Biosciences INC VTUS | Director | filed 2010 - 2019 |
| RCS Capital Corp RCAP | Director | filed 2013 - 2015 |
| Optimer Pharmaceuticals INC OPTR | Director | filed 2007 - 2013 |
| Collexis Holdings, Inc. [CLXS] | Director | filed 2007 - 2008 |
| Neuro-Hitech, Inc. NHPI.OB | Director | filed 2006 - 2008 |
| Southridge Technology Group, Inc. SOUT | Director | filed 2007 - 2008 |
| PAR Pharmaceutical Companies, INC. prx | Director · Executive Chairman | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.